title: Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study.
authors.affiliation: Experimental Heart Transplant Group, Frankfurt, Germany.
authors.forename: M H C
authors.initials: MH
authors.lastname: Richter
authors.forename: H
authors.initials: H
authors.lastname: Richter
authors.forename: M
authors.initials: M
authors.lastname: Barten
authors.forename: D
authors.initials: D
authors.lastname: Schramm
authors.forename: J
authors.initials: J
authors.lastname: Gummert
authors.forename: F W
authors.initials: FW
authors.lastname: Mohr
authors.forename: M
authors.initials: M
authors.lastname: Skupin
authors.forename: H G
authors.initials: HG
authors.lastname: Olbrich
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D003327:Coronary Disease / Q000517:prevention & control*; D004656:Enalapril / Q000494:pharmacology; D016027:Heart Transplantation / Q000473:pathology / Q000502:physiology*; D019808:Losartan / Q000494:pharmacology*; D023421:Models, Animal; D011183:Postoperative Complications / Q000517:prevention & control; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D044140:Receptor, Angiotensin, Type 1; D014652:Vascular Diseases / Q000517:prevention & control*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D044140:Receptor, Angiotensin, Type 1; D004656:Enalapril; D019808:Losartan